Clinical Drug Experience Knowledgebase

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Anemia (Phase 1)

Anemia, Iron-Deficiency (Phase 4)

Asthma (Phase 2)

Atrial Fibrillation (Phase 2)

Atrophy (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Transitional Cell (Phase 3)

Cerebral Infarction (Phase 3)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 3)

Congenital Abnormalities (Phase 2)

Deficiency Diseases (Phase 1)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Dizziness (Phase 2)

Dry Socket (Phase 4)

Eczema (Phase 3)

Fatigue (Phase 4)

Fibromyalgia (Phase 3)

Glioma (Phase 2)

Hemangioma (Phase 3)

Hemangioma, Capillary (Phase 3)

Hyperplasia (Phase 4)

Infections (Phase 3)

Inflammation (Phase 4)

Ischemia (Phase 3)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Melanoma (Phase 2)

Mesothelioma (Phase 2)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 3)

Myofascial Pain Syndromes (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Onychomycosis (Phase 4)

Osteitis (Phase 4)

Pelvic Neoplasms (Phase 1)

Pharyngitis (Phase 3)

Port-Wine Stain (Phase 3)

Prostatic Hyperplasia (Phase 4)

Respiratory Tract Infections (Phase 3)

Schizophrenia (Phase 2)

Sclerosis (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Stress, Psychological (Phase 2)

Stroke (Phase 3)

Syndrome (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Ureteral Neoplasms (Phase 2)

Urethral Neoplasms (Phase 1)

Urinary Bladder Neoplasms (Phase 3)

Urinary Tract Infections (Phase 3)

Urticaria (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Vertigo (Phase 2)